Iron

phospholipase A2 group VI ; Homo sapiens







30 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35122944 Vitamin E prevents lipid peroxidation and iron accumulation in PLA2G6-Associated Neurodegeneration. 2022 Apr 2
2 34387792 Novel deep intronic mutation in PLA2G6 causing early-onset Parkinson's disease with brain iron accumulation through pseudo-exon activation. 2021 Oct 1
3 30302010 PLA2G6-associated neurodegeneration presenting as a complicated form of hereditary spastic paraplegia. 2019 Jan 1
4 30707893 Impaired iPLA2β activity affects iron uptake and storage without iron accumulation: An in vitro study excluding decreased iPLA2β activity as the cause of iron deposition in PLAN. 2019 Jun 1 7
5 31489256 Neurodegeneration with Brain Iron Accumulation: Two Additional Cases with Dystonic Opisthotonus. 2019 1
6 29916839 Aripiprazole in a Patient of PLA2G6-Associated Neurodegeneration With Psychosis. 2018 Jul/Aug 1
7 30042723 Heterozygous PLA2G6 Mutation Leads to Iron Accumulation Within Basal Ganglia and Parkinson's Disease. 2018 1
8 27942883 Mutation screening of PLA2G6 in Japanese patients with early onset dystonia-parkinsonism. 2017 Apr 1
9 27141409 Mitochondrial dysfunction and defects in lipid homeostasis as therapeutic targets in neurodegeneration with brain iron accumulation. 2016 1
10 24361204 C19orf12 mutation leads to a pallido-pyramidal syndrome. 2014 Mar 10 1
11 24522175 Ophthalmic features of PLA2G6-related paediatric neurodegeneration with brain iron accumulation. 2014 Jul 1
12 22934738 Follow-up study of 25 Chinese children with PLA2G6-associated neurodegeneration. 2013 Feb 1
13 23182313 Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease. 2013 Jan 2
14 23791636 Specific roles for Group V secretory PLA₂ in retinal iron-induced oxidative stress. Implications for age-related macular degeneration. 2013 Aug 2
15 24130795 New findings in a global approach to dissect the whole phenotype of PLA2G6 gene mutations. 2013 1
16 24209433 Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes. 2013 1
17 20619503 Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. 2012 Apr 2
18 22515743 PLA2G6 mutations and other rare causes of neurodegeneration with brain iron accumulation. 2012 Aug 1
19 22732705 Differential participation of phospholipase A2 isoforms during iron-induced retinal toxicity. Implications for age-related macular degeneration. 2012 Oct 1
20 19855947 Phospholipases A2 and inflammatory responses in the central nervous system. 2010 Jun 1
21 20629144 Indian-subcontinent NBIA: unusual phenotypes, novel PANK2 mutations, and undetermined genetic forms. 2010 Jul 30 1
22 20686114 Imaging decreased brain docosahexaenoic acid metabolism and signaling in iPLA(2)β (VIA)-deficient mice. 2010 Nov 1
23 20886109 Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism. 2010 Sep 23 1
24 20938027 Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism. 2010 Oct 12 3
25 18570303 Characterization of PLA2G6 as a locus for dystonia-parkinsonism. 2009 Jan 2
26 19087156 R632W mutation in PLA2G6 segregates with dystonia-parkinsonism in a consanguineous Iranian family. 2009 Jan 1
27 18202189 Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations. 2008 Feb 2
28 18799783 Neurodegeneration associated with genetic defects in phospholipase A(2). 2008 Oct 28 3
29 16783378 PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. 2006 Jul 2
30 17101456 Neuroferritinopathy. 2006 Sep 1